Females received 1 injection (3 µg-dose, on day 0 of N5), or 2 injections (3 µg each,
on day 0 and day 3 of N5, respectively) of dsMock (control) or dsKr-h1 (treated). (a)
Effects on BgKr-h1 mRNA levels measured by qRT-PCR on days 2, 4 and 6 of N5 in
single-injection experiments, or on day 6 of N5 in two-injection experiments. (b) Length
(days) of N5 in control and treated female specimens. (c) Percentage of specimens
showing the intermediate nymph-adult phenotype or the precocious adult phenotype in the
1- or 2-injection experiments. (d) Dorsal and ventral view of phenotypes resulting from
1- or 2-injection experiments, compared with control females in last nymphal instar and
with the adult stage. (e) Dorsal part of the thorax in the intermediate nymph-adult
phenotype, showing the membranous structure of the wing pads. Data in (a) represent 4
biological replicates (mean ± SEM) and are normalized against the dsMock females
(reference value = 1); the asterisk indicates statistically significant differences with
respect to controls (p < 0.05), according to the REST software tool40.
Replicates in (b) are indicated at the top of each bar; the asterisk indicates that
differences with the respective controls are statistically significant (student’s
t-test, P<0.001).